Phio Pharmaceuticals Corp [PHIO] stock prices are up 4.88% to $1.29 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PHIO shares have gain 7.50% over the last week, with a monthly amount drifted -30.65%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, H.C. Wainwright started tracking the stock with Buy rating on August 05, 2020, and set its price target to $4.
The stock price of Phio Pharmaceuticals Corp [PHIO] has been fluctuating between $0.97 and $9.79 over the past year. Phio Pharmaceuticals Corp [NASDAQ: PHIO] shares were valued at $1.29 at the most recent close of the market.
Analyzing the PHIO fundamentals
Gross Profit Margin for this corporation currently stands at -14.84% with Operating Profit Margin at -83.64%, Pretax Profit Margin comes in at -113.61%, and Net Profit Margin reading is -113.61%. To continue investigating profitability, this company’s Return on Assets is posted at -0.69, Equity is -0.86 and Total Capital is -0.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.2133 points at the first support level, and at 1.1367 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3433, and for the 2nd resistance point, it is at 1.3967.
Ratios To Look Out For
It’s worth pointing out that Phio Pharmaceuticals Corp [NASDAQ:PHIO]’s Current Ratio is 6.90. As well, the Quick Ratio is 6.90, while the Cash Ratio is 20.75.
Transactions by insiders
Recent insider trading involved Bitterman Robert J, Chairman, Pres. & CEO, that happened on Nov 21 ’25 when 5000.0 shares were purchased. Chairman, Pres. & CEO, Bitterman Robert J completed a deal on Nov 18 ’25 to buy 5000.0 shares. Meanwhile, Chairman, Pres & CEO Bitterman Robert J bought 2000.0 shares on Jun 10 ’25.
